https://www.selleckchem.com/products/apatinib.html
The aim of this study was to detect predisposing CV risks factors and ECGs changes in COVID-19 patients. The study population included 60 noncritically ill patients with COVID-19 pneumonia admitted to our hospital between 16 March and 11 May 2020. Electrographic changes, evaluated from ECGs acquired at admission and at 7 days after starting COVID-19 therapy, were analysed. We also compared 45 patients without CV involvement with 15 patients with new onset of cardiac adverse events during hospitalization. ECGs under treatment showed a l
Like
Comment
Share
